Accuracy of magnetic resonance imaging for predicting pathological complete response of breast cancer after neoadjuvant chemotherapy: association with breast cancer subtype
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2193-1801
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Accuracy of magnetic resonance imaging for predicting pathological complete response of breast cancer after neoadjuvant chemotherapy: association with breast cancer subtype ; volume:5 ; number:1 ; day:24 ; month:2 ; year:2016 ; pages:1-9 ; date:12.2016
SpringerPlus ; 5, Heft 1 (24.2.2016), 1-9, 12.2016
- Urheber
-
Fukuda, Takayo
- Beteiligte Personen und Organisationen
-
Horii, Rie
Gomi, Naoya
Miyagi, Yumi
Takahashi, Shunji
Itō, Yoshinori
Akiyama, Futoshi
Ohno, Shinji
Iwase, Takuji
SpringerLink (Online service)
- DOI
-
10.1186/s40064-016-1800-x
- URN
-
urn:nbn:de:1111-201602255582
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Fukuda, Takayo
- Horii, Rie
- Gomi, Naoya
- Miyagi, Yumi
- Takahashi, Shunji
- Itō, Yoshinori
- Akiyama, Futoshi
- Ohno, Shinji
- Iwase, Takuji
- SpringerLink (Online service)
Ähnliche Objekte (12)
The association between breast density and breast cancer pathological response to neoadjuvant chemotherapy
Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: breast cancer subtype analyses
Whole-exome profiles of inflammatory breast cancer and pathological response to neoadjuvant chemotherapy
Biomarker dynamics affecting neoadjuvant therapy response and outcome of HER2-positive breast cancer subtype
Familial relative risks for breast cancer by pathological subtype: a population-based cohort study
Pathological complete response to neoadjuvant chemotherapy in triple negative breast cancer – single hospital experience
The E2F4 prognostic signature predicts pathological response to neoadjuvant chemotherapy in breast cancer patients
Predicting pathological axillary lymph node status with ultrasound following neoadjuvant therapy for breast cancer
Prediction of neoadjuvant chemotherapy response in breast cancer
Neoadjuvant Treatment of Breast Cancer - Advances and Limitations
Radiation Management for Breast Cancer After Neoadjuvant Therapy
Shrink pattern of breast cancer after neoadjuvant chemotherapy and its correlation with clinical pathological factors
The association between breast density and breast cancer pathological response to neoadjuvant chemotherapy
Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: breast cancer subtype analyses
Whole-exome profiles of inflammatory breast cancer and pathological response to neoadjuvant chemotherapy
Biomarker dynamics affecting neoadjuvant therapy response and outcome of HER2-positive breast cancer subtype
Familial relative risks for breast cancer by pathological subtype: a population-based cohort study
Pathological complete response to neoadjuvant chemotherapy in triple negative breast cancer – single hospital experience
The E2F4 prognostic signature predicts pathological response to neoadjuvant chemotherapy in breast cancer patients
Predicting pathological axillary lymph node status with ultrasound following neoadjuvant therapy for breast cancer
Prediction of neoadjuvant chemotherapy response in breast cancer
Neoadjuvant Treatment of Breast Cancer - Advances and Limitations
Radiation Management for Breast Cancer After Neoadjuvant Therapy
Shrink pattern of breast cancer after neoadjuvant chemotherapy and its correlation with clinical pathological factors
The association between breast density and breast cancer pathological response to neoadjuvant chemotherapy
Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: breast cancer subtype analyses
Whole-exome profiles of inflammatory breast cancer and pathological response to neoadjuvant chemotherapy
Biomarker dynamics affecting neoadjuvant therapy response and outcome of HER2-positive breast cancer subtype
Familial relative risks for breast cancer by pathological subtype: a population-based cohort study
Pathological complete response to neoadjuvant chemotherapy in triple negative breast cancer – single hospital experience
The E2F4 prognostic signature predicts pathological response to neoadjuvant chemotherapy in breast cancer patients
Predicting pathological axillary lymph node status with ultrasound following neoadjuvant therapy for breast cancer
Prediction of neoadjuvant chemotherapy response in breast cancer
Neoadjuvant Treatment of Breast Cancer - Advances and Limitations
Radiation Management for Breast Cancer After Neoadjuvant Therapy